Synapse - Works

Results (4925)

Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis

Meeting Abstract

Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
Blood (2017)

Fulltext@MSK | Save

Peripheral neuropathy is an under-recognized feature of monoclonal gammopathy of undetermined significance: A population-based study of 18,668 MGUS patients and their 97,641 matched controls

Meeting Abstract

Rögnvaldsson, S.; Steingrímsson, V.; Turesson, I.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
Blood (2017)

Fulltext@MSK | Save

Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning

Meeting Abstract

Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littmann, E. R.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
Blood (2017)

Fulltext@MSK | Save

Risk-adapted therapy in adults with Burkitt lymphoma: Results of NCI 9177, a multicenter prospective phase II study of DA-EPOCH-R

Meeting Abstract

Roschewski, M.; Dunleavy, K.; Abramson, J. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P.; Mitsuyasu, R. T.; Battini, R.; Watson, P. R.; more...
Blood (2017)

Fulltext@MSK | Save

Analysis of healthcare provider practice patterns from individual patient cases entered into an online treatment decision tool for chronic lymphocytic leukemia (CLL)

Meeting Abstract

Rosenthal, K. M.; Awan, F. T.; Coutre, S.; Jones, J. A.; Sharman, J. P.; Obholz, K. L.; Zelenetz, A. D.
Blood (2017)

Fulltext@MSK | Save

Addition of polatuzumab vedotin to bendamustine and rituximab (BR) improves outcomes in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) versus BR alone: Results from a randomized phase 2 study

Meeting Abstract

Sehn, L. H.; Herrera, A. F.; Matasar, M. J.; Kamdar, M.; McMillan, A. K.; Kim, T. M.; Kim, W. S.; Hertzberg, M.; Ozcan, M.; Penuel, E.; more...
Blood (2017)

Fulltext@MSK | Save

Venetoclax plus rituximab is superior to bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia - Results from pre-planned interim analysis of the randomized phase 3 Murano study

Meeting Abstract

Seymour, J. F.; Kipps, T. J.; Eichhorst, B. F.; Hillmen, P.; D'Rozario, J. M.; Assouline, S.; Owen, C. J.; Gerecitano, J.; Robak, T.; De la Serna, J.; more...
Blood (2017)

Fulltext@MSK | Save

Expression of major histocompatibility complex (MHC) class II, but not MHC class I, predicts outcome in patients with classical Hodgkin lymphoma (cHL) treated with nivolumab (programmed death-1 [PD-1] blockade)

Meeting Abstract

Roemer, M. G. M.; Redd, R. A.; Cader, F. Z.; Pak, C. J.; Abdelrahman, S.; Ouyang, J.; Sasse, S.; Younes, A.; Fanale, M. A.; Santoro, A.; more...
Blood (2017)

Fulltext@MSK | Save

Adults receiving defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final results from the expanded-access program

Meeting Abstract

Richardson, P. G.; Antin, J. H.; Giralt, S. A.; Ryan, R. J.; Liang, W.; Hume, R. L.; Tappe, W. M.; Kernan, N. A.
Blood (2017)

Fulltext@MSK | Save

Pooled analysis of day +100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) and ventilator or dialysis dependence following hematopoietic stem cell transplantation (HSCT)

Meeting Abstract

Richardson, P. G.; Smith, A. R.; Kernan, N. A.; Antin, J. H.; Lehmann, L.; Ryan, R. J.; Hume, R. L.; Tappe, W. M.; Grupp, S. A.
Blood (2017)

Fulltext@MSK | Save